Home NIV treatment quality in patients with chronic respiratory failure having participated to the French nationwide telemonitoring experimental program (The TELVENT study) - 15/09/23
, Joelle Texereau b, c, Arnaud Prigent d, Jésus Gonzalez-Bermejo e, f, Claudio Rabec g, Frédéric Gagnadoux h, Alexia Letierce i, Joao Carlos Winck jAbstract |
Background |
The ETAPES program is a national telemedicine experiment conducted in France between 2018 and 2023 to investigate whether home non-invasive ventilation (NIV) telemonitoring improves healthcare pathways in patients with chronic respiratory failure (CRF) and impacts healthcare organization. The program provides a combination of therapeutic education and NIV telemonitoring with data processed by an algorithm generating alerts. The TELVENT study objective was to analyze the evolution of ventilation quality in patients included in the ETAPES program.
Methods |
Multicentric cohort study on patients undergoing long-term NIV included in the ETAPES program between September 2018 and December 2020 and who did not refuse the use of their data for this research. Data were obtained from homecare provider databases. The primary endpoint was to attain successful NIV treatment, which was determined by a combination of daily NIV usage for > 4 h per day, low leaks, and a low apnea-hypopnea index (AHI) identified by the NIV device. Respiratory disability was assessed using the DIRECT questionnaire.
Results |
329 patients were included in the study of which 145 had COPD and 83 had started NIV and ETAPES within one-month delay. Approximately 25% of patients did not achieve the criteria for successful NIV at ETAPES entry. The proportion of patients with successful NIV treatment increased to 86.8% at six months (p = 0.003, Cochran-Armitage trend test) regardless of NIV history and continued to increase at 12 months in newly equipped NIV patients (93.8%, at month 12, p = 0.0026 for trend test). Over time, a significant increase in NIV use and compliance was observed, while AHI significantly decreased in the overall population. No significant decrease was observed for non-intentional leaks. Approximately 4.9 alerts were generated per patient per 6 months. Their number and type (low NIV use, high AHI or leaks) differed among patients based on their NIV history. Respiratory disability score decreased over time compared with baseline.
Conclusion |
The TELVENT study highlights the importance of remote NIV monitoring to rapidly identify patients with unsuccessful ventilation. The combination of remote monitoring and therapeutic education may improve the quality of home NIV, especially in the first months of treatment.
Le texte complet de cet article est disponible en PDF.Keywords : ETAPES, Telemonitoring, NIV, Chronic respiratory failure
Plan
Vol 84
Article 101028- novembre 2023 Retour au numéro
Article précédent
- Recovery of Endothelium-dependent vascular relaxation impairment in convalescent COVID-19 patients: Insight from a pilot study
- Fares Gouzi, Aurélien Philippe, Jean Pastre, Bertrand Renaud, Nicolas Gendron, Marielle Subileau, Thông Hua-Huy, Benjamin Planquette, Olivier Sanchez, David M. Smadja, Sven Günther
- Eosinophil recovery in hospitalized COVID-19 patients is associated with lower rates of ICU admission and in-hospital mortality: An observational cohort analysis
- Peter D. Yan, Daniela Markovic, Roxana Y. Hixson, Carolyn M. Shover, Russell G. Buhr, Ramin Salehi-Rad, Blake LeMaster, Donald P. Tashkin, Jennifer A. Fulcher, Igor Z. Barjaktarevic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?